Showing results (71-80 of 148) with videos related to
Sort By:
Pageof 15
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Willingness to pay for diagnostic technologies: a review of the contingent valuation literaturePei-Jung Lin, Michael J Cangelosi, David W Lee, et al.Clinics in Chest Medicine|August 21, 2018
The Value of Bedside Echocardiogram in the Setting of Acute and Chronic Pulmonary EmbolismDavid W Lee, Kavitha Gopalratnam, Hubert James Ford, et al.Journal of the American Chemical Society|February 12, 2009
Animal pigment bilirubin discovered in plantsCary Pirone, J Martin E Quirke, Horacio A Priestap, et al.JAMA Cardiology|September 30, 2016
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical TrialBenjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, et al.Journal of the American College of Cardiology|June 2, 2018
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REALMatthew A Cavender, Anna Norhammar, Kåre I Birkeland, et al.American Heart Journal|May 13, 2015
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trialMichelle L O'Donoghue, Ruchira Glaser, Philip E Aylward, et al.Circulation|May 20, 2017
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, et al.Diabetes, Obesity & Metabolism|March 24, 2018
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL studyMikhail Kosiborod, Kåre I Birkeland, Matthew A Cavender, et al.Journal of the American College of Cardiology|November 10, 2012
Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarctionAndrew N Rassi, Matthew A Cavender, Gregg C Fonarow, et al.JACC. Cardiovascular Interventions|February 5, 2021
Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data RegistryDavid M Safley, Adam C Salisbury, Thomas T Tsai, et al.Pageof 15